Alembic Pharmaceuticals Ltd.

Financial

	Alembic Pharma	Jubilant Pharmova	Caplin Point Lab
Operational Metrics
Pharmaceutical Sector
US DMF Filings	140.0 .	98.0 .	n/a
Number of ANDA's Filed in USA	266.0 .	100.0 .	51.0 .
Number of ANDA's Approved By USFDA	220.0 .	62.0 .	38.0 .
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in Canada	21.0	24.0	n/a
Number of ANDA's Approved by Canada	20.0	24.0	n/a
Number of ANDA's Filed in Europe	21.0	38.0	n/a
Number of ANDA's Approved in Europe	19.0	37.0	n/a
R&D as a % of Total Sales	9.0 %	0.33 %	4.6 %
Financials
5 yr Average ROE	12.89 %	8.35 %	20.61 %
5yr average Equity Multiplier	1.39	2.0	1.17
5yr Average Asset Turnover Ratio	0.86	0.59	0.72
5yr Avg Net Profit Margin	11.15 %	7.13 %	24.8 %
Price to Book	3.67	2.85	5.56
P/E	32.69	21.23	29.53
5yr Avg Cash Conversion Cycle	9.46 Days	-19.21 Days	79.85 Days
Inventory Days	99.1 Days	81.78 Days	64.55 Days
Days Receivable	66.32 Days	51.11 Days	100.92 Days
Days Payable	164.9 Days	173.51 Days	74.04 Days
5yr Average Interest Coverage Ratio	30.59	3.98	579.71
5yr Avg ROCE	15.26 %	9.05 %	25.27 %
5yr Avg Operating Profit Margin	17.29 %	18.69 %	30.87 %
5 yr average Debt to Equity	0.14	0.64	0.01
5yr CAGR Net Profit	-12.64 %	-38.8 %	16.28 %
5yr Average Return on Assets	9.32 %	4.23 %	17.7 %
Shareholdings
Promoter Holding	69.67 %	50.68 %	70.56 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.06 %	0.0	1.67 %
Change in Mutual Fund Holding (3 Yrs)	4.02 %	3.61 %	0.55 %

Business

	Alembic Pharma	Jubilant Pharmova	Caplin Point Lab
Product Wise Break-Up	Product Wise Break-Up Formulations 80.68 Active Pharmaceutical Ingredient (API) 19.32 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Branded Generic 0 Generic 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 9.26 India branded pharmaceuticals 0.72 Specialty intermediates 0 Formulations 0 Life science chemicals 0 Branded Generic 0 Generic 0 Nutritional products 0 Contract Research and Development Services 6.7 Solid dosage formulations 10.82 Contract Manufacturing 16.81 Anti-allergic 10.21 Active Pharmaceutical Ingredient (API) 0 Radiopharmaceuticals 44.9 Others 0.58	Product Wise Break-Up Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Specialty intermediates 0 Formulations 0 Life science chemicals 0 Branded Generics 25.0 Formulations 75.0 Nutritional products 0 0 Solid dosage formulations 0 0 Allergy therapy products 0 Active Pharmaceutical Ingredient (API) 0 Radiopharmaceuticals 0
Product Wise Break-Up	Product Wise Break-Up Formulations 80.68 Active Pharmaceutical Ingredient (API) 19.32 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Branded Generic 0 Generic 0	Product Wise Break-Up Active Pharmaceutical Ingredient (API) 9.26 India branded pharmaceuticals 0.72 Specialty intermediates 0 Formulations 0 Life science chemicals 0 Branded Generic 0 Generic 0 Nutritional products 0 Contract Research and Development Services 6.7 Solid dosage formulations 10.82 Contract Manufacturing 16.81 Anti-allergic 10.21 Active Pharmaceutical Ingredient (API) 0 Radiopharmaceuticals 44.9 Others 0.58	Product Wise Break-Up Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Specialty intermediates 0 Formulations 0 Life science chemicals 0 Branded Generics 25.0 Formulations 75.0 Nutritional products 0 0 Solid dosage formulations 0 0 Allergy therapy products 0 Active Pharmaceutical Ingredient (API) 0 Radiopharmaceuticals 0
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.12 India 39.88 China 0 Americas and Europe 0 USA 0 Africa 0 LATAM 0	Location Wise Break-Up USA 0 India 2.33 Africa 0 China 0 Rest of the World 7.5 Americas and Europe 90.17 LATAM 0	Location Wise Break-Up USA 18.0 India 0 Africa 6.0 China 0 Rest of the World 0 Americas and Europe 0 Latin America 76.0
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

SIGN UP FOR FREE